Skip to main content
Skip to main content
MED logo

Medifast, Inc. (MED)

$11.04 +$0.08 (+0.73%) |Weak · 39
Bottom line: HOLD — our Council read (39/100) and AI Score (39/100) broadly agree.
MCap: $122.76M| Vol: 118.7K| Target: $12.00 (+8.7%)| 52-wk range: $9.22 – $15.46
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Medifast, Inc. (MED) trades at $11.04 with AI Score 39/100 (Grade D). Medifast, Inc. develops and distributes weight loss, weight management, and healthy living products. Market cap: $122.76M, Sector: Consumer cyclical.

Price live · AI analysis from May 10, 2026
Medifast, Inc. develops and distributes weight loss, weight management, and healthy living products. The company operates primarily in the United States and the Asia-Pacific region, marketing its products through an e-commerce platform.

MED stock analysis for 2026: Analysts have set a consensus price target of $12.00 for Medifast, Inc., suggesting 8.7% upside from the current price of $11.04. The AI MoonshotScore is 39/100, indicating a bearish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
HOLD 39/100 · D

MED: 1/1 perspectives are bearish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Medifast, Inc. (MED) Consumer Business Overview

CEODaniel R. Chard
Employees504
HeadquartersBaltimore, MD, US
IPO Year1993

Medifast, Inc. (MED) is a consumer cyclical company focused on weight management and healthy living products, primarily marketed through its OPTAVIA program. With a presence in the US and Asia-Pacific, Medifast faces competition in a dynamic market driven by evolving consumer preferences and health trends.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for MED?

Medifast, Inc. presents a mixed investment case. The company's gross margin of 70.1% indicates strong pricing power. However, a negative profit margin of -5.8% raises concerns about operational efficiency and cost management. The company's beta of 0.56 suggests lower volatility compared to the market. Growth catalysts include expansion in the Asia-Pacific market and continued innovation in product offerings. Potential risks include increased competition in the weight loss industry and fluctuations in consumer spending. Investors should closely monitor Medifast's ability to improve profitability and maintain market share in a competitive environment.

Based on FMP financials and quantitative analysis

MED Key Highlights

  • Market capitalization of $122.76M, reflecting its current valuation in the market.
  • Gross margin of 70.1%, indicating strong pricing power and efficient cost of goods sold management.
  • Negative profit margin of -5.8%, suggesting challenges in managing operating expenses and achieving profitability.
  • Beta of 0.56, indicating lower volatility compared to the broader market.
  • Operates in the Consumer Cyclical sector, making it sensitive to economic cycles and consumer spending patterns.

Who Are MED's Competitors?

MED is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
WW WW International, Inc. $16.35 +0.25% $163.48M 45
ROVR Rover Group, Inc. $10.99 +0.05% $2.00B 62
CVSA Covista Inc. $130.15 +0.20% $4.43B 58
CVSGF CVS Group plc $15.65 -5.44% $1.08B 52
RGS Regis Corporation $27.50 +1.49% $68.73M 51
EM Smart Share Global Limited $1.20 +0.00% $303.05M 39
BIMT Bitmis Corp. $2.20 +0.00% $15.95M 38
MUGH Mu Global Holding Limited $2.00 +14.29% $118.87M 38

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are MED's Key Strengths?

  • Established brand reputation in the weight loss industry.
  • Proprietary OPTAVIA program with a network of independent coaches.
  • High gross margin of 70.1%.
  • Direct-to-consumer sales model through e-commerce platform.

What Are MED's Weaknesses?

  • Negative profit margin of -5.8%.
  • Dependence on independent coaches for sales and customer support.
  • Limited geographic presence compared to larger competitors.
  • Vulnerability to changing consumer preferences and health trends.

What Could Drive MED Stock Higher?

  • Potential positive impact from new product launches in the health and wellness category.
  • Continued expansion of the OPTAVIA program and its network of independent coaches.
  • Growth in e-commerce sales and digital marketing initiatives.

What Are the Key Risks for MED?

  • Negative return on equity (-9.7%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Increased competition from other weight loss programs and nutritional product manufacturers.
  • Fluctuations in consumer spending and economic cycles.
  • Negative profit margin impacting overall financial performance.
  • Regulatory changes and shifting consumer attitudes towards health and wellness.

What Are the Growth Opportunities for MED?

  • Expansion in the Asia-Pacific Market: Medifast has the opportunity to further expand its presence in the Asia-Pacific region, tapping into a large and growing market for weight management products. This expansion could involve strategic partnerships, localized product offerings, and targeted marketing campaigns. The Asia-Pacific market presents significant growth potential due to increasing disposable incomes and rising health awareness, with the weight management market projected to reach billions of dollars in the coming years. Timeline: Ongoing.
  • Product Innovation and New Product Development: Medifast can drive growth through continuous product innovation and the development of new offerings that cater to evolving consumer preferences. This includes exploring new flavors, formats, and ingredients, as well as incorporating technological advancements into its products and services. The market for innovative health and wellness products is constantly expanding, with consumers seeking convenient and effective solutions. Timeline: Ongoing.
  • Enhancement of the OPTAVIA Program: Medifast can further enhance its OPTAVIA program by incorporating personalized coaching, digital tools, and community support. This includes leveraging data analytics to provide customized recommendations and tracking progress. The OPTAVIA program's success depends on its ability to deliver tangible results and foster long-term behavior change. The market for personalized health and wellness solutions is growing rapidly. Timeline: Ongoing.
  • Strategic Partnerships and Collaborations: Medifast can pursue strategic partnerships and collaborations with complementary businesses, such as fitness centers, healthcare providers, and corporate wellness programs. These partnerships can expand its reach and provide access to new customer segments. The market for integrated health and wellness solutions is gaining traction, with consumers seeking comprehensive approaches to health management. Timeline: Ongoing.
  • E-commerce Optimization and Digital Marketing: Medifast can optimize its e-commerce platform and digital marketing efforts to enhance customer acquisition and retention. This includes improving website usability, leveraging social media marketing, and implementing targeted advertising campaigns. The e-commerce channel is crucial for Medifast's growth, with online sales accounting for a significant portion of its revenue. The market for online health and wellness products is highly competitive. Timeline: Ongoing.

What Opportunities Does MED Have?

  • Expansion in the Asia-Pacific market.
  • Product innovation and new product development.
  • Enhancement of the OPTAVIA program with personalized coaching and digital tools.
  • Strategic partnerships and collaborations with complementary businesses.

What Threats Does MED Face?

  • Increased competition from other weight loss programs and nutritional product manufacturers.
  • Fluctuations in consumer spending and economic cycles.
  • Regulatory changes and shifting consumer attitudes towards health and wellness.
  • Potential for negative publicity or product recalls.

What Are MED's Competitive Advantages?

  • Brand recognition and reputation in the weight loss industry.
  • Proprietary OPTAVIA program with a network of independent coaches.
  • Established e-commerce platform for direct-to-consumer sales.
  • Formulation and branding of consumable health and nutritional products.

What Does MED Do?

Founded in 1980 and headquartered in Baltimore, Maryland, Medifast, Inc. has evolved into a prominent player in the weight loss and healthy living sector. The company manufactures and distributes a range of products designed for weight loss, weight management, and overall health. Its product portfolio includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups. These products are marketed under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. Medifast primarily utilizes an e-commerce platform to reach its customers, facilitating direct-to-consumer sales and personalized coaching through its OPTAVIA program. The company operates in the United States and the Asia-Pacific region, catering to a diverse customer base seeking weight management solutions and healthier lifestyles. Medifast's business model emphasizes a holistic approach to weight loss, combining nutritional products with coaching and community support.

What Products and Services Does MED Offer?

  • Manufactures weight loss, weight management, and healthy living products.
  • Distributes products in the United States and the Asia-Pacific region.
  • Offers a range of products including bars, shakes, soups, and snacks.
  • Markets products under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands.
  • Utilizes an e-commerce platform for direct-to-consumer sales.
  • Provides coaching and community support through the OPTAVIA program.

How Does MED Make Money?

  • Direct-to-consumer sales through its e-commerce platform.
  • Network of independent OPTAVIA coaches who provide personalized support and guidance.
  • Subscription-based model for recurring product purchases.
  • Emphasis on community and social support to enhance customer engagement and retention.

What Industry Does MED Operate In?

Medifast operates within the competitive personal products and services industry, which is characterized by evolving consumer preferences and health trends. The market for weight loss and weight management products is substantial, driven by increasing health awareness and obesity rates. Medifast competes with other weight loss programs, nutritional product manufacturers, and direct-to-consumer health companies. The industry is also influenced by regulatory changes and shifting consumer attitudes towards health and wellness. Medifast's success depends on its ability to differentiate its products, maintain customer loyalty, and adapt to changing market dynamics.

Who Are MED's Key Customers?

  • Individuals seeking weight loss and weight management solutions.
  • Health-conscious consumers looking for healthy living products.
  • Customers in the United States and the Asia-Pacific region.
  • Individuals seeking personalized coaching and support through the OPTAVIA program.
AI Confidence: 81% Updated: May 10, 2026

Net buyingInsider Activity

Over the past six months, Medifast, Inc. insiders filed 23 SEC Form 4 transactions — 8 sales and 15 purchases. On net that is roughly 162K shares acquired (about $87K) — insiders putting money in tends to read as conviction.

FY2026 estForward Outlook

Wall Street analysts project Medifast, Inc. revenue of about $279.7M for fiscal 2026, with EPS near $-1.85.

F-Score 3/9Financial Health

Medifast, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 4.24 places it in the safe zone, indicating low near-term bankruptcy risk.

ROE -10%Key Financial Metrics

Return on equity for Medifast, Inc. stands at -9.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.9%, showing how much profit it generates from its asset base. Its free cash flow yield is -1.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 4.80 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -16.6%, the inverse of the P/E and a quick read on earnings relative to price.

Medifast, Inc. (MED) Valuation Context

Valued at $122.76M, MED is classified as a micro-cap stock. Relative to its peer group, MED's quantitative score of 39/100 is below the peer average of 54/100.

Company Profile

Medifast, Inc. operates in the Personal Products & Services industry within the Consumer Cyclical sector. It is headquartered in Baltimore, US. The company is led by CEO Daniel R. Chard. MED has traded publicly since 1993.

MED Financials

Fundamental Snapshot

Revenue Growth (FY)
-36.0%
Free Cash Flow Growth (FY)
-92.7%
Return on Equity (TTM)
-9.7%
Current Ratio
4.8
EV/EBITDA (TTM)
10.4

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in Medifast's future performance, indicating that those closest to the company believe in its potential.
  • Community sentiment has shifted positively, with many traders discussing the company's innovative product offerings and their alignment with health trends.
  • The growing focus on health and wellness in society positions Medifast well, as more consumers seek meal replacement options for weight management.
  • Recent partnerships and collaborations have been highlighted, suggesting that Medifast is expanding its market reach and enhancing brand visibility.

Bear Case

  • Concerns about potential supply chain disruptions have surfaced, which could impact product availability and customer satisfaction.
  • Some traders express skepticism regarding the sustainability of Medifast's growth, citing increased competition in the health and wellness sector.
  • Negative sentiment arises from recent earnings reports that, while not disastrous, failed to meet the more optimistic expectations set by analysts.
  • There are discussions around the company's reliance on a single product line, raising questions about long-term diversification and risk management.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

MED Latest News

MED Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MED.

Price Targets

Consensus target: $12.00

MED MoonshotScore

39/100

What does this score mean?

The MoonshotScore rates MED's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Daniel R. Chard

Chief Executive Officer

Daniel R. Chard serves as the Chief Executive Officer of Medifast, Inc. His background includes extensive experience in the consumer goods and direct selling industries. Prior to joining Medifast, he held leadership positions at various companies, where he focused on driving growth, improving operational efficiency, and enhancing customer engagement. His expertise spans across marketing, sales, and product development. He is responsible for overseeing Medifast's strategic direction and day-to-day operations.

Track Record: Under Daniel R. Chard's leadership, Medifast has focused on expanding its OPTAVIA program and enhancing its e-commerce platform. He has overseen the company's efforts to innovate its product offerings and strengthen its brand reputation. Key milestones during his tenure include expanding the company's presence in the Asia-Pacific market and improving customer retention rates. He is focused on driving long-term sustainable growth and creating value for shareholders.

MED Consumer Cyclical Stock FAQ

What does Medifast, Inc. do?

Medifast, Inc. is a manufacturer and distributor of weight loss, weight management, and healthy living products. The company operates primarily in the United States and the Asia-Pacific region. Its core offering revolves around the OPTAVIA program, which combines nutritional products with personalized coaching and community support. Medifast's business model centers on direct-to-consumer sales through its e-commerce platform and a network of independent OPTAVIA coaches. The company aims to provide comprehensive solutions for individuals seeking to achieve and maintain a healthy weight and lifestyle.

What do analysts say about MED stock?

Analyst coverage of Medifast, Inc. (MED) presents a mixed outlook. Some analysts highlight the company's strong gross margin and the potential for growth in the weight management market. However, concerns remain regarding its negative profit margin and increasing competition. Valuation metrics vary, with some analysts citing a potential upside based on future growth prospects, while others express caution due to current financial challenges. The consensus view suggests a neutral stance, with investors advised to closely monitor the company's ability to improve profitability and maintain market share.

What are the main risks for MED?

Medifast, Inc. faces several key risks. Increased competition in the weight loss and nutritional product market could erode its market share. Fluctuations in consumer spending and economic cycles may impact demand for its products. The company's negative profit margin poses a significant financial risk, requiring improved cost management and operational efficiency. Regulatory changes and shifting consumer attitudes towards health and wellness could also affect its business model and product offerings. Dependence on independent OPTAVIA coaches creates a reliance on their performance and retention.

How does Medifast, Inc. adapt to changing consumer preferences?

Medifast, Inc. adapts to evolving consumer preferences through continuous product innovation and the enhancement of its OPTAVIA program. The company invests in research and development to create new flavors, formats, and ingredients that cater to changing tastes and dietary trends. It also incorporates technological advancements into its products and services, such as personalized coaching apps and digital tracking tools. Medifast actively monitors consumer feedback and market trends to identify emerging needs and preferences, allowing it to adjust its offerings and marketing strategies accordingly. This proactive approach helps maintain relevance and competitiveness in the dynamic health and wellness market.

What is MED's dividend and shareholder return track record?

Medifast, Inc. currently does not offer a dividend to its shareholders. The company has not historically paid dividends, and there are no current plans to initiate a dividend program. As a result, shareholder returns are primarily dependent on stock price appreciation. The absence of a dividend may be a consideration for investors seeking income-generating investments. Medifast's capital allocation strategy focuses on reinvesting in growth initiatives, such as product development, market expansion, and e-commerce optimization. The company's management believes that these investments will generate higher returns for shareholders in the long term.

What are the key factors to evaluate for MED?

Medifast, Inc. (MED) holds an AI score of 39/100 (low). Analysts target $12.00 (+9%). Not financial advice.

How frequently does MED data refresh on this page?

MED prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven MED's recent stock price performance?

Medifast, Inc. (MED) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brand reputation in the weight loss industry. See the News tab for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
  • Financial metrics are as of the latest available reporting period.
Data Sources

Popular Stocks